non-small cell lung cancer (NSCLC)
Conditions
Interventions
Experimental group:Chemotherapy combined with the addition of Jin Shui Liu Jun Decoction
Control group:Chemotherapy
Sponsors
The First Affiliated Hospital of Hebei North University
Eligibility
Sex/Gender
All
Age
18 Years to 78 Years
Inclusion criteria
Inclusion criteria: 1. The patient was diagnosed with Stage III to IV non-small cell lung cancer by pathology or cytology and was diagnosed with EGFR wild type by genetic test; 2. Karnofaky score >=60, predicted survival of more than 3 months; 3. Patients unable or unwilling to undergo surgery; 4. Aged <=78 years; 5. All examination indicators are in line with indications of chemotherapy; 6. Patients with observable tumor foci, willing to accept the treatment program, able to adhere to medication according to the doctor's advice, good compliance, patients can be followed up, TCM syndrome differentiation is Qi and Yin deficiency, heat stasis internal resistance.
Exclusion criteria
Exclusion criteria: 1. Those with cognitive impairment who cannot cooperate well or limited education level who cannot understand and fill in the form; 2. Failure of heart, lung, liver, kidney and other major organs; 3. Patients who are allergic to drugs used in this study; 4. Mental and neurological disorders, unable to express their wishes correctly; 5. Pregnant patients, lactating patients and patients of childbearing age who do not take contraceptive measures; 6. Patients currently participating in clinical trials of other drugs or medical devices.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease control rate;Objective response rate (ORR); | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM evidence score;Karnofaky score;Immune cytokines; | — |
Countries
China
Contacts
Public ContactLiu Daiwei
The First Affiliated Hospital of Hebei North University
Outcome results
None listed